Announcements Trials
Browse Landscape

Phase

Phase 1 19Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 48Prostatic Neoplasms 33Breast Neoplasms 23Stomach Neoplasms 16Squamous Cell Carcinoma of Head and Neck 15Lung Neoplasms 15Esophageal Neoplasms 13Neoplasm Metastasis 11Sarcoma 9Neoplasms 9Colorectal Neoplasms 7Urinary Bladder Neoplasms 6Ovarian Neoplasms 6Head and Neck Neoplasms 6Carcinoma, Transitional Cell 6Carcinoma, Renal Cell 6Melanoma 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Small Cell Lung Carcinoma 4Carcinoma, Ovarian Epithelial 4Breast Neoplasms, Male 4Salivary Gland Neoplasms 3Prostatic Neoplasms, Castration-Resistant 3Pancreatic Neoplasms 3Non-Muscle Invasive Bladder Neoplasms 3Leiomyosarcoma 3Inflammatory Breast Neoplasms 3Endometrial Neoplasms 3Carcinoma, Squamous Cell 3

Interventions

sargramostim 2Topotecan 2timcodar 1bempegaldesleukin 1Tissue Plasminogen Activator 1Radiotherapy 1Radiosurgery 1Paclitaxel 1Muromonab-CD3 1Irinotecan 1Interferon-alpha 1Immunization, Passive 1Gemcitabine 1Docetaxel 1Diathermy 1Cyclophosphamide 1Cisplatin 1Captopril 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Unspecified Adult Solid Tumor, Protocol Specific × Docetaxel × Clear all
NCT00004923 2009-08-25

Docetaxel and Irinotecan in Treating Patients With Advanced Solid Tumors

Yale University

Phase 1/2 Completed
47 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡